期刊文献+

CT引导下^(125)Ⅰ粒子植入治疗难治性盆腔恶性肿瘤 被引量:13

Percutaneous CT guided interstial ^(125)Ⅰ seeds implantation for refractory pelvic malignant tumors;efficacy and technique
下载PDF
导出
摘要 目的评价CT引导下125Ⅰ粒子组织间植入治疗盆腔难治性恶性肿瘤的临床疗效,探讨粒子植入技术。方法23例盆腔恶性肿瘤,均为术后复发接受化疗和(或)根治量放疗肿瘤仍进展患者,瘤体最大径3.5~7.0 cm,平均4.5 cm。粒子植入术前1~3 d行模拟CT扫描,采用治疗计划系统(TPS)制定粒子植入计划,根据处方剂量求出术中所需125Ⅰ粒子的总活度并算出治疗粒子数量。在CT引导下经皮穿刺植入125Ⅰ粒子。其中6例患者粒子植入前或后接受髂内动脉灌注化疗。结果单个瘤体内首次植入粒子数为9~75粒,平均27粒。6例接受髂内动脉灌注化疗共14个疗程。粒子植入术后72 h~4周,下肢疼痛和(或)肛门、会阴周围疼痛坠胀不适,完全缓解5例,部分缓解11例,有效率69.6%(16/23)。术后随访2~34个月,中位随访21个月,部分缓解(PR)18例;无变化(SD)4例;进展(PD)1例,总有效率78.3%(18/23)。死亡3例,存活20例,最长生存时间34个月。结论CT引导下125Ⅰ粒子植入对盆腔难治性恶性肿瘤安全、有效。 Objective To evaluate the efficacy of percutaneous CT guided interstitial ^125I seeds implantation treatment for refractory pelvic malignant tumors and discuss the procedure of technique. Methods Twenty-three patients with refractory pelvic malignant tumors(25 lesions, diameter 3.5-7.0 cm, mean 4.5 cm) showing failure response to full chemotherapy and/or radical radiotherapy after tumors resection were undergone percutaneous CT guided intratumoral ^125I seed implantation. Treatment plan system(TPS)was used to design the distribution and number of ^125I seeds according to matched peripheral dose (MPD)1-3 days before the procedure. Of which 6 cases received combined internal iliac arterial infusion chemotherapy before or after the ^125I seed implantation procedure. Results 9 - 75(mean 27)^125I seeds were implanted into a single tumor at first time including 6 patients with intraarterial chemotherapy for 14 cycles (mean 2.3 cycles), showed relief of clinical pain symptoms in 16 of 23 cases, 72 h - 4 w after the seeds implantation; with the an effective rate of 69.6%. Follow up for 2-34 months (median, 21 months), CT or MRI performed 2 months after the seeds implantation showed no CR, but PR in 18 cases, SD in 4 cases, and PD in 1 case, with overall response rate of 78% (18/23), and no serious complication. In addition, 20 cases survived, with the longest one of 34 months and the other 3 died. Conclusions Intratumoral ^125I seeds implantation under CT guidance for pelvic refractory malignant tumors is safe, minimally invasive, and effective.
出处 《介入放射学杂志》 CSCD 2008年第5期343-345,共3页 Journal of Interventional Radiology
关键词 盆腔恶性肿瘤 难治性 近距离放射疗法 ^125粒子 Pelvic malignant tumors Refractory Brachytherapy,^125I seed
  • 相关文献

参考文献9

二级参考文献24

  • 1黄振国,张雪哲,王武,洛小林,王继英.CT导引下^(125)I粒子植入在治疗恶性肿瘤中的应用[J].中华放射学杂志,2004,38(9):921-925. 被引量:135
  • 2李孟达.宫颈复发癌的诊断和治疗[J].实用妇产科杂志,1994,10(5):242-244. 被引量:15
  • 3王俊杰,黄毅,冉维强,朱丽红,白静,田素青,李金娜.^(125)I粒子近距离治疗前列腺癌临床应用[J].中华放射医学与防护杂志,2004,24(6):509-512. 被引量:38
  • 4Langley SE, Laing RW. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer[J]. Prostate Cancer Prostatic Dis,2004,7(3):201-207.
  • 5Keyes M, Pickles T, Agranovich A, et al. 125Ⅰ reimplantation in patients with poor initial dosimetry after prostate brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2004, 60(1): 40-50.
  • 6Tu AS, Geyer CA, Mancall AC, et al. The buccal space: a doorway for percutaneous CT-guided biopsy of the parapharyngeal region. AJNR Am J Neuroradiol, 1998,19:728-731.
  • 7Robbins KT, vanSonnenberg E, Casola G, et al. Image-guided needle biopsy of inaccessible head and neck lesions. Arch Otolaryngol Head Neck Surg, 1990, 116: 957-961.
  • 8Barakos JA, Dillon WP. Lesions of the foramen ovale: CT-guided fine-needle aspiration. Radiology, 1992, 182: 573-575.
  • 9Sherman PM, Yousem DM, Loevner LA. CT-guided aspirations in the head and neck: assessment of the first 216 cases. AJNR Am J Neuroradiol, 2004, 25: 1603-1607.
  • 10Oliai BR, Sheth S, Burroughs FH, et al. "Parapharyngeal space" tumors: a cytopathological study of 24 cases on fine-needle aspiration. Diagn Cytopathol, 2005, 32: 11-15.

共引文献85

同被引文献109

引证文献13

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部